SynGap Missense Server

Table of SynGAP1 Isoform α2 (UniProt Q96PV0-1) Missense Variants.

c.dna Variant SGM Consensus Domain ClinVar gnomAD ESM1b AlphaMissense REVEL FoldX Rosetta Foldetta PremPS PROVEAN PolyPhen-2 HumDiv PolyPhen-2 HumVar FATHMM SIFT PAM Physical SASA Normalized B-factor backbone Normalized B-factor sidechain SynGAP Structural Annotation DOI
Clinical Status Review Subm. ID Allele count Allele freq. LLR score Prediction Pathogenicity Class Optimized Score Prediction Average ΔΔG Prediction StdDev ΔΔG Prediction ΔΔG Prediction ΔΔG Prediction Score Prediction pph2_prob Prediction pph2_prob Prediction Nervous System Score Prediction Prediction Status Conservation Sequences PAM250 PAM120 Hydropathy Δ MW Δ Average Δ Δ StdDev Δ StdDev Secondary Tertiary bonds Inside out GAP-Ras interface At membrane No effect MD Alert Verdict Description
c.1345A>GS449G
(3D Viewer)
Likely BenignGAPUncertain 16-33438250-A-G31.86e-6-5.936Likely Benign0.071Likely BenignLikely Benign0.116Likely Benign0.47Likely Benign0.00.55Ambiguous0.51Ambiguous0.85Ambiguous-2.32Neutral0.948Possibly Damaging0.124Benign3.35Benign0.13Tolerated3.3732010.4-30.03
c.2270G>CG757ALikely BenignUncertain 1-2.626Likely Benign0.091Likely BenignLikely Benign0.066Likely Benign-0.45Neutral0.267Benign0.127Benign2.73Benign0.35Tolerated102.214.03
c.3170G>AS1057NLikely BenignUncertain 1-6.386Likely Benign0.117Likely BenignLikely Benign0.218Likely Benign-0.41Neutral0.451Benign0.129Benign5.25Benign0.28Tolerated11-2.727.03
c.1222A>GT408AC2Uncertain 1-8.304Likely Pathogenic0.114Likely BenignLikely Benign0.118Likely Benign0.37Likely Benign0.6-0.06Likely Benign0.16Likely Benign0.72Ambiguous-3.07Deleterious0.540Possibly Damaging0.131Benign4.16Benign0.14Tolerated102.5-30.03
c.2840G>CG947ALikely BenignLikely Benign 16-33443392-G-C281.73e-5-6.511Likely Benign0.080Likely BenignLikely Benign0.156Likely Benign-0.41Neutral0.224Benign0.131Benign4.97Benign0.10Tolerated4.324102.214.03
c.2669G>AR890HLikely BenignBenign 16-33443221-G-A191.18e-5-3.600Likely Benign0.198Likely BenignLikely Benign0.056Likely Benign-1.29Neutral0.254Benign0.134Benign3.97Benign0.15Tolerated4.324201.3-19.05
c.2221C>TP741SLikely BenignUncertain 26-33441686-C-T31.86e-6-3.700Likely Benign0.063Likely BenignLikely Benign0.076Likely Benign-0.27Neutral0.270Benign0.136Benign2.92Benign0.00Affected4.3221-10.8-10.0410.1016/j.ajhg.2020.11.011
c.2405G>AG802DLikely BenignSH3-binding motifUncertain 16-33442957-G-A16.20e-7-5.083Likely Benign0.476AmbiguousLikely Benign0.153Likely Benign-0.38Neutral0.126Benign0.138Benign2.72Benign0.09Tolerated3.7751-1-3.158.04
c.3511G>AA1171TLikely BenignCoiled-coilUncertain 1-3.658Likely Benign0.149Likely BenignLikely Benign0.201Likely Benign-0.48Neutral0.245Benign0.138Benign5.45Benign0.07Tolerated4.32410-2.530.03
c.3184G>AG1062RLikely BenignConflicting 26-33443736-G-A74.35e-6-6.933Likely Benign0.353AmbiguousLikely Benign0.403Likely Benign-0.34Neutral0.797Possibly Damaging0.139Benign4.10Benign0.01Affected4.322-3-2-4.199.14
c.373C>TP125SLikely BenignUncertain 1-3.769Likely Benign0.238Likely BenignLikely Benign0.121Likely Benign-3.57Deleterious0.580Possibly Damaging0.140Benign2.86Benign0.02Affected3.6151-10.8-10.04
c.1702G>TV568L
(3D Viewer)
Likely PathogenicGAPUncertain 1-9.503Likely Pathogenic0.921Likely PathogenicAmbiguous0.651Likely Pathogenic-0.30Likely Benign0.30.57Ambiguous0.14Likely Benign0.56Ambiguous-2.69Deleterious0.511Possibly Damaging0.147Benign-1.23Pathogenic0.04Affected3.373512-0.414.03
c.2881C>TH961YLikely BenignConflicting 26-33443433-C-T31.86e-6-8.051Likely Pathogenic0.157Likely BenignLikely Benign0.102Likely Benign-1.07Neutral0.716Possibly Damaging0.147Benign4.10Benign0.55Tolerated3.775021.926.03
c.3824G>AR1275QLikely BenignUncertain 16-33447872-G-A21.29e-6-4.928Likely Benign0.121Likely BenignLikely Benign0.103Likely Benign-1.72Neutral0.898Possibly Damaging0.147Benign2.59Benign0.03Affected3.775111.0-28.06
c.3662G>AR1221QLikely BenignCoiled-coilConflicting 26-33446654-G-A42.48e-6-5.491Likely Benign0.115Likely BenignLikely Benign0.078Likely Benign-1.46Neutral0.836Possibly Damaging0.153Benign2.56Benign0.12Tolerated3.775111.0-28.06
c.1142G>TG381V
(3D Viewer)
Likely BenignC2Uncertain 16-33438047-G-T21.25e-6-5.967Likely Benign0.146Likely BenignLikely Benign0.618Likely Pathogenic7.16Destabilizing1.04.10Destabilizing5.63Destabilizing-0.32Likely Benign-0.95Neutral0.386Benign0.157Benign1.32Pathogenic0.10Tolerated4.329-1-34.642.08214.6-68.80.30.7-0.50.3UncertainGly381 is located in the Gly-rich Ω loop (res. Pro364-Pro398) between two anti-parallel β sheet strands (res. Thr359-Pro364, res. Ala399-Ile411). Because the Ω loop is assumed to directly interact with the membrane, it moves arbitrarily throughout the WT solvent simulations. The Ω loop potentially plays a crucial role in the SynGAP-membrane complex association, stability, and dynamics. However, this aspect cannot be fully addressed through solvent simulations alone.Ω loops are known to play major roles in protein functions that require flexibility, and thus hydrophobic residues like valine are rarely tolerated. Although no negative structural effects are observed in the variant simulations, Val381 may exert drastic effects on the SynGAP-membrane complex dynamics and stability. However, since the effects on Gly-rich Ω loop dynamics can only be well studied through the SynGAP-membrane complex, no definite conclusions can be drawn.
c.3250C>GP1084ALikely BenignUncertain 1-3.928Likely Benign0.066Likely BenignLikely Benign0.114Likely Benign-2.54Deleterious0.649Possibly Damaging0.157Benign4.05Benign0.35Tolerated3.775-113.4-26.04
c.3368G>AG1123DUncertain 16-33443920-G-A21.33e-6-10.321Likely Pathogenic0.405AmbiguousLikely Benign0.360Likely Benign-0.78Neutral0.500Possibly Damaging0.157Benign4.34Benign0.19Tolerated3.7751-1-3.158.04
c.526A>CS176RLikely BenignUncertain 1-6.492Likely Benign0.987Likely PathogenicLikely Pathogenic0.247Likely Benign0.94Neutral0.718Possibly Damaging0.168Benign4.16Benign0.87Tolerated0-1-3.769.11
c.2998A>GI1000VLikely BenignUncertain 2-4.102Likely Benign0.098Likely BenignLikely Benign0.086Likely Benign-0.20Neutral0.437Benign0.170Benign2.76Benign0.81Tolerated4.32434-0.3-14.03
c.1976C>TS659F
(3D Viewer)
Likely PathogenicGAPUncertain 1-10.925Likely Pathogenic0.662Likely PathogenicLikely Benign0.194Likely Benign-0.81Ambiguous0.1-0.25Likely Benign-0.53Ambiguous0.32Likely Benign-4.59Deleterious0.806Possibly Damaging0.171Benign3.39Benign0.05Affected3.3828-3-23.660.10221.3-61.20.00.00.60.4XPotentially BenignIn the WT simulations, the hydroxyl group of Ser659, located in a kink in the middle of the long α-helix (res. Ser641-Glu666), forms a hydrogen bond with the carboxylate group of Glu656. However, the phenol ring of the Phe659 side chain cannot form a similar hydrogen bond. Instead, it interacts with the hydrophobic isopropyl side chain of Val555 from the opposing α-helix (res. Ala533-Val560). This residue swap may therefore cause issues during protein folding.
c.1480A>GI494V
(3D Viewer)
GAPConflicting 26-33438512-A-G362.23e-5-7.102In-Between0.112Likely BenignLikely Benign0.439Likely Benign1.16Ambiguous0.00.71Ambiguous0.94Ambiguous1.02Destabilizing-0.83Neutral0.278Benign0.179Benign-1.30Pathogenic0.07Tolerated3.373543-0.3-14.03248.629.30.00.0-1.10.5XPotentially BenignThe sec-butyl side chain of Ile494, located in an α-helix (res. Leu489-Glu519), packs against hydrophobic residues (e.g., Phe484, Leu465, Trp572, Ala493, Met468) in an inter-helix space (res. Leu489-Glu519 and res. Ala461-Phe476). In the variant simulations, the hydrophobic iso-propyl side chain of Val494, which is of a similar size and has similar physicochemical properties to Ile494 in the WT, resides similarly in the inter-helix hydrophobic space. Thus, no negative effects on the protein structure are observed.
c.163C>AQ55KLikely BenignUncertain 26-33423572-C-A241.49e-5-5.840Likely Benign0.612Likely PathogenicLikely Benign0.085Likely Benign-1.21Neutral0.140Benign0.184Benign3.91Benign0.00Affected4.32111-0.40.04
c.3287A>CE1096ALikely BenignUncertain 1-4.504Likely Benign0.510AmbiguousLikely Benign0.164Likely Benign-1.37Neutral0.626Possibly Damaging0.184Benign2.77Benign0.16Tolerated3.775-105.3-58.04
c.86T>CM29TLikely BenignUncertain 1-2.167Likely Benign0.122Likely BenignLikely Benign0.199Likely Benign-0.37Neutral0.018Benign0.184Benign4.33Benign0.00Affected4.321-1-1-2.6-30.09
c.28C>TR10WLikely BenignUncertain 16-33420292-C-T21.30e-6-5.707Likely Benign0.503AmbiguousLikely Benign0.236Likely Benign-0.31Neutral0.964Probably Damaging0.190Benign4.10Benign0.00Affected4.3212-33.630.03
c.2277G>AM759ILikely BenignUncertain 16-33441742-G-A16.20e-7-4.058Likely Benign0.393AmbiguousLikely Benign0.075Likely Benign-0.88Neutral0.454Possibly Damaging0.192Benign2.83Benign0.34Tolerated3.995122.6-18.03
c.2214T>GS738RLikely BenignBenign 16-33441679-T-G16.20e-7-4.241Likely Benign0.570Likely PathogenicLikely Benign0.068Likely Benign-1.55Neutral0.473Possibly Damaging0.193Benign2.69Benign0.01Affected4.3220-1-3.769.11
c.3314G>AR1105QLikely BenignUncertain 26-33443866-G-A31.96e-6-3.666Likely Benign0.216Likely BenignLikely Benign0.104Likely Benign-1.21Neutral0.958Probably Damaging0.194Benign2.50Benign0.16Tolerated3.775111.0-28.06
c.4013G>AR1338QLikely BenignConflicting 36-33451887-G-A128.40e-6-3.494Likely Benign0.317Likely BenignLikely Benign0.076Likely Benign-1.87Neutral0.896Possibly Damaging0.194Benign3.81Benign0.02Affected3.775111.0-28.06
c.3290C>TP1097LLikely BenignBenign 1-4.410Likely Benign0.145Likely BenignLikely Benign0.131Likely Benign-2.07Neutral0.611Possibly Damaging0.198Benign2.64Benign0.05Affected3.775-3-35.416.04
c.2743G>AG915SLikely BenignBenign 16-33443295-G-A95.58e-6-3.557Likely Benign0.083Likely BenignLikely Benign0.050Likely Benign-0.88Neutral0.801Possibly Damaging0.201Benign2.73Benign0.31Tolerated3.77510-0.430.03
c.662A>GE221G
(3D Viewer)
Likely PathogenicPHUncertain 1-12.221Likely Pathogenic0.992Likely PathogenicLikely Pathogenic0.863Likely Pathogenic1.40Ambiguous0.11.74Ambiguous1.57Ambiguous0.71Ambiguous-5.56Deleterious0.596Possibly Damaging0.201Benign5.79Benign0.00Affected0-23.1-72.06
c.662A>TE221V
(3D Viewer)
Likely PathogenicPHLikely Pathogenic 1-14.954Likely Pathogenic0.987Likely PathogenicLikely Pathogenic0.875Likely Pathogenic-0.66Ambiguous0.2-0.89Ambiguous-0.78Ambiguous0.49Likely Benign-5.54Deleterious0.596Possibly Damaging0.203Benign5.86Benign0.00Affected3.4113-2-27.7-29.98234.550.60.00.0-0.40.2XUncertainThe introduced residue Val221 is located on the outer surface of an anti-parallel β sheet strand (res. Cys219-Thr224). Unlike the carboxylate group of Glu221, Val221 cannot form hydrogen bonds with Thr223 or a salt bridge with the amino group of the Lys207 side chain. Despite this, the WT simulations containing Glu221 do not show significant differences compared to the variant simulations. However, since the model ends abruptly at the N-terminus, no definite conclusions can be drawn from the simulations.
c.53A>GY18CLikely BenignUncertain 16-33420317-A-G442.88e-5-2.658Likely Benign0.251Likely BenignLikely Benign0.102Likely Benign-0.56Neutral0.872Possibly Damaging0.206Benign4.04Benign0.00Affected4.3210-23.8-60.04
c.3395C>AS1132YLikely BenignLikely Benign 1-5.894Likely Benign0.392AmbiguousLikely Benign0.401Likely Benign-1.76Neutral0.500Possibly Damaging0.208Benign5.40Benign0.09Tolerated4.324-3-2-0.576.10
c.1771G>AA591T
(3D Viewer)
Likely PathogenicGAPConflicting 36-33440823-G-A181.12e-5-9.572Likely Pathogenic0.704Likely PathogenicLikely Benign0.270Likely Benign1.61Ambiguous0.21.00Ambiguous1.31Ambiguous1.19Destabilizing-3.40Deleterious0.955Possibly Damaging0.209Benign3.48Benign0.01Affected3.373510-2.530.03202.9-43.40.20.00.70.1XPotentially BenignThe methyl group of the Ala591 side chain, located in the middle of an α helix (res. Glu582-Met603), packs against hydrophobic residues (e.g., Ile483, Phe484) of an opposing partially helical loop (res. Phe476-Asn487).In the variant simulations, the hydroxyl group of Thr591 can form hydrogen bonds with the backbone carbonyl of Ile843 in the opposing loop or the backbone carbonyl group of Arg587. These interactions could either reinforce the tertiary assembly or weaken the α helix unity. Additionally, the Thr591 side chain can hydrogen bond with the guanidinium group of the Arg587 side chain, potentially strengthening the α helix unity.Overall, the residue swap does not seem to cause any major negative effects on the protein structure.
c.313T>CS105PLikely BenignUncertain 1-3.631Likely Benign0.166Likely BenignLikely Benign0.204Likely Benign0.03Neutral0.808Possibly Damaging0.212Benign4.00Benign0.00Affected4.321-11-0.810.04
c.1322T>CV441A
(3D Viewer)
GAPConflicting 26-33438227-T-C31.86e-6-9.439Likely Pathogenic0.359AmbiguousLikely Benign0.053Likely Benign-0.14Likely Benign0.00.33Likely Benign0.10Likely Benign0.95Ambiguous-2.92Deleterious0.513Possibly Damaging0.214Benign3.44Benign0.93Tolerated3.372900-2.4-28.05195.044.60.00.10.50.0XXUncertainThe iso-propyl side chain of Val441, located on the outer surface of an α helix (res. Asn440-Thr458), does not interact with other residues in the WT simulations. In the variant simulations, the methyl side chain of Ala441 is similarly hydrophobic and does not form any interactions on the outer helix surface. Although the residue swap does not negatively affect the protein structure based on the simulations, it is noteworthy that the residue faces the RasGTPase interface. Thus, the effect of the residue swap on the SynGAP-Ras complex formation or GTPase activation cannot be fully addressed using the SynGAP solvent-only simulations.
c.2932C>TP978SLikely BenignUncertain 1-3.913Likely Benign0.151Likely BenignLikely Benign0.085Likely Benign-1.07Neutral0.481Possibly Damaging0.220Benign4.22Benign0.48Tolerated1-10.8-10.04
c.3920C>TP1307LLikely BenignBenign 16-33451794-C-T116.82e-6-4.044Likely Benign0.144Likely BenignLikely Benign0.292Likely Benign-1.49Neutral0.779Possibly Damaging0.220Benign2.82Benign0.04Affected3.775-3-35.416.04
c.2029A>TS677C
(3D Viewer)
Likely BenignGAPBenign 1-8.496Likely Pathogenic0.076Likely BenignLikely Benign0.153Likely Benign-0.51Ambiguous0.3-0.30Likely Benign-0.41Likely Benign0.15Likely Benign-2.41Neutral0.932Possibly Damaging0.222Benign3.25Benign0.04Affected3.4123-103.316.06
c.194A>GH65RLikely BenignUncertain 16-33425802-A-G16.20e-7-1.980Likely Benign0.967Likely PathogenicLikely Pathogenic0.073Likely Benign-1.60Neutral0.462Possibly Damaging0.227Benign4.19Benign0.00Affected4.32120-1.319.05
c.2596G>TV866LLikely BenignUncertain 16-33443148-G-T16.20e-7-3.352Likely Benign0.148Likely BenignLikely Benign0.046Likely Benign-0.97Neutral0.217Benign0.229Benign2.71Benign0.21Tolerated3.82421-0.414.03
c.3508A>GS1170GLikely BenignCoiled-coilUncertain 1-4.288Likely Benign0.221Likely BenignLikely Benign0.349Likely Benign-0.81Neutral0.241Benign0.229Benign5.31Benign0.54Tolerated4.324100.4-30.03
c.1673A>GH558R
(3D Viewer)
Likely PathogenicGAPUncertain 1-14.445Likely Pathogenic0.554AmbiguousLikely Benign0.587Likely Pathogenic-1.14Ambiguous0.1-0.23Likely Benign-0.69Ambiguous1.03Destabilizing-4.94Deleterious0.677Possibly Damaging0.239Benign-1.24Pathogenic0.14Tolerated3.373502-1.319.05
c.2825C>TP942LLikely BenignUncertain 16-33443377-C-T42.48e-6-5.063Likely Benign0.086Likely BenignLikely Benign0.048Likely Benign-2.00Neutral0.411Benign0.239Benign2.37Pathogenic0.00Affected4.324-3-35.416.04
c.2924C>TT975ILikely BenignUncertain 16-33443476-C-T63.72e-6-3.912Likely Benign0.164Likely BenignLikely Benign0.068Likely Benign-1.66Neutral0.411Benign0.239Benign4.11Benign0.66Tolerated4.3220-15.212.05
c.3152G>AG1051DBenign 16-33443704-G-A21.24e-6-9.379Likely Pathogenic0.311Likely BenignLikely Benign0.445Likely Benign-0.31Neutral0.761Possibly Damaging0.239Benign-0.74Pathogenic0.39Tolerated3.775-11-3.158.04
c.1913A>GK638R
(3D Viewer)
Likely BenignGAPUncertain 1-2.700Likely Benign0.110Likely BenignLikely Benign0.216Likely Benign0.09Likely Benign0.1-0.04Likely Benign0.03Likely Benign0.53Ambiguous-2.55Deleterious0.649Possibly Damaging0.240Benign3.41Benign0.13Tolerated3.373123-0.628.01
c.694G>AA232T
(3D Viewer)
PHBenign 16-33435545-G-A16.20e-7-7.655In-Between0.874Likely PathogenicAmbiguous0.469Likely Benign0.47Likely Benign0.1-0.04Likely Benign0.22Likely Benign0.61Ambiguous-1.42Neutral0.608Possibly Damaging0.240Benign5.80Benign0.09Tolerated3.401410-2.530.03210.8-42.00.50.10.40.5XUncertainThe hydroxyl group of Thr232, located at the end of an anti-parallel β sheet strand (res. Thr228-Ala232), forms hydrogen bonds with nearby residues Glu217, Cys233, and Cys219 in the variant simulations. These hydrogen-bonding interactions at the β sheet surface contribute to the stability of the secondary structure element and prevent it from unfolding. The new hydrogen bond interactions may be more favorable for structural stability than the steric interactions of the methyl side chain of Ala with the side chains of Gln216 and Cys219 in the WT. However, since the model ends abruptly at the N-terminus, no definite conclusions can be drawn from the simulations.
c.2300T>CI767TLikely BenignUncertain 1-3.749Likely Benign0.252Likely BenignLikely Benign0.138Likely Benign-0.78Neutral0.625Possibly Damaging0.249Benign4.12Benign0.46Tolerated3.6460-1-5.2-12.05
c.2818G>AG940SLikely BenignUncertain 16-33443370-G-A16.20e-7-5.451Likely Benign0.084Likely BenignLikely Benign0.135Likely Benign0.45Neutral0.409Benign0.253Benign2.77Benign0.44Tolerated3.77510-0.430.03
c.1193C>TP398L
(3D Viewer)
C2Uncertain 16-33438098-C-T84.96e-6-7.518In-Between0.547AmbiguousLikely Benign0.599Likely Pathogenic1.48Ambiguous0.2-0.54Ambiguous0.47Likely Benign0.62Ambiguous-7.10Deleterious0.961Probably Damaging0.256Benign5.72Benign0.01Affected3.4016-3-35.416.04245.8-68.6-0.10.0-0.30.2XPotentially PathogenicPro398 is located in the Gly-rich Ω loop (res. Pro364-Pro398) between two anti-parallel β sheet strands (res. Thr359-Pro364 and res. Ala399-Ile411). The Ω loop is assumed to directly interact with the membrane, and it is observed to move arbitrarily throughout the WT solvent simulations. Although the residue swap does not influence the nearby secondary structure elements, proline is often found at the ends of β sheets due to its disfavored status during folding.Additionally, the Ω loop potentially plays a crucial role in the SynGAP-membrane complex association, stability, and dynamics. However, this aspect cannot be fully addressed through solvent simulations alone. Ω loops are known to play significant roles in protein functions that require flexibility, and thus hydrophobic residues like leucine are rarely tolerated. Although no negative structural effects are visualized in the variant’s simulations, Leu398 may exert drastic effects on the SynGAP-membrane complex dynamics and stability. Since the effects on the Gly-rich Ω loop dynamics can only be well studied through the SynGAP-membrane complex, no definite conclusions can be drawn.
c.3607C>GH1203DLikely BenignCoiled-coilUncertain 1-6.729Likely Benign0.525AmbiguousLikely Benign0.403Likely Benign-1.89Neutral0.473Possibly Damaging0.265Benign5.51Benign0.24Tolerated3.7751-1-0.3-22.05
c.3161G>AG1054DUncertain 1-10.385Likely Pathogenic0.351AmbiguousLikely Benign0.279Likely Benign-0.26Neutral0.818Possibly Damaging0.266Benign4.07Benign0.37Tolerated3.7751-1-3.158.04
c.1121C>AS374Y
(3D Viewer)
C2Uncertain 1-7.774In-Between0.344AmbiguousLikely Benign0.310Likely Benign0.71Ambiguous1.20.66Ambiguous0.69Ambiguous-0.02Likely Benign-1.18Neutral0.875Possibly Damaging0.271Benign5.41Benign0.01Affected4.3213-3-2-0.576.10237.3-76.90.50.40.50.3UncertainSer374 is located in the Gly-rich Ω loop (res. Pro364-Pro398) between two anti-parallel β sheet strands (res. Thr359-Pro364, res. Ala399-Ile411). Because the Ω loop is assumed to directly interact with the membrane, it moves arbitrarily throughout the WT solvent simulations. The Ω loop potentially plays a crucial role in the SynGAP-membrane complex association, stability, and dynamics. However, this aspect cannot be fully addressed through solvent simulations alone.Ω loops are known to play major roles in protein functions that require flexibility, and thus, large and relatively hydrophobic residues like tyrosine are rarely tolerated. Additionally, the hydroxyl group of Tyr374 frequently forms various hydrogen bonds with other loop residues in the variant simulations. Although no negative structural effects are observed in the variant simulations, Tyr374 may exert drastic effects on the SynGAP-membrane complex dynamics and stability. However, since the effect on Gly-rich Ω loop dynamics can only be studied through the SynGAP-membrane complex, no definite conclusions can be drawn.
c.484C>GR162GLikely BenignUncertain 1-6.985Likely Benign0.664Likely PathogenicLikely Benign0.190Likely Benign-0.73Neutral0.487Possibly Damaging0.272Benign4.09Benign0.78Tolerated3.744-2-34.1-99.14
c.2111G>AS704N
(3D Viewer)
Likely BenignGAPBenign/Likely benign 36-33441370-G-A271.67e-5-5.917Likely Benign0.421AmbiguousLikely Benign0.058Likely Benign0.48Likely Benign0.1-0.12Likely Benign0.18Likely Benign0.54Ambiguous-0.49Neutral0.771Possibly Damaging0.275Benign3.39Benign0.08Tolerated3.471011-2.727.03233.2-29.1-0.10.0-0.10.1XPotentially BenignSer704 is located at the end and outer surface of an α-helix (res. Thr704-Gly712), which is connected via a tight turn or loop to another α-helix (res. Asp684-Gln702). The hydroxyl side chain of Ser704 occasionally forms a hydrogen bond with the amide group of Ala707. However, in the variant simulations, the carboxamide side chain of Asn704 achieves more lasting and numerous hydrogen-bonding interactions with the residues at the helix end, such as Glu706, Ala707, and Leu708. Consequently, the residue swap could strengthen the α-helix secondary structure integrity at the helix end, which could have either positive or negative effects on its function.
c.3824G>TR1275LLikely Benign 16-33447872-G-T16.45e-7-6.052Likely Benign0.446AmbiguousLikely Benign0.117Likely Benign-4.04Deleterious0.800Possibly Damaging0.277Benign2.55Benign0.01Affected3.775-3-28.3-43.03
c.3121C>TP1041SLikely BenignConflicting 26-33443673-C-T16.20e-7-4.246Likely Benign0.121Likely BenignLikely Benign0.344Likely Benign-2.72Deleterious0.664Possibly Damaging0.283Benign5.48Benign0.11Tolerated3.7751-10.8-10.04
c.2924C>AT975NLikely BenignUncertain 16-33443476-C-A16.20e-7-4.671Likely Benign0.089Likely BenignLikely Benign0.100Likely Benign-0.58Neutral0.586Possibly Damaging0.302Benign4.13Benign0.07Tolerated4.32200-2.813.00
c.3053C>TT1018IUncertain 16-33443605-C-T42.48e-6-3.264Likely Benign0.524AmbiguousLikely Benign0.076Likely Benign-2.55Deleterious0.586Possibly Damaging0.304Benign2.24Pathogenic0.01Affected3.775-105.212.05
c.2657C>TA886VLikely BenignUncertain 16-33443209-C-T181.12e-5-4.478Likely Benign0.078Likely BenignLikely Benign0.061Likely Benign-0.20Neutral0.888Possibly Damaging0.314Benign2.17Pathogenic0.00Affected4.324002.428.05
c.866T>CM289TLikely BenignC2Uncertain1-4.668Likely Benign0.238Likely BenignLikely Benign0.222Likely Benign0.73Ambiguous0.10.17Likely Benign0.45Likely Benign-0.01Likely Benign-0.47Neutral0.801Possibly Damaging0.315Benign1.83Pathogenic0.57Tolerated-1-1-2.6-30.09
c.2750C>GP917RLikely BenignUncertain 16-33443302-C-G53.10e-6-4.475Likely Benign0.363AmbiguousLikely Benign0.142Likely Benign-1.70Neutral0.642Possibly Damaging0.316Benign2.68Benign0.00Affected3.775-20-2.959.07
c.2873A>CH958PLikely BenignBenign 16-33443425-A-C21.24e-6-8.369Likely Pathogenic0.068Likely BenignLikely Benign0.204Likely Benign-0.36Neutral0.925Possibly Damaging0.316Benign4.14Benign0.10Tolerated3.7750-21.6-40.02
c.2381C>TP794LLikely BenignSH3-binding motifBenign/Likely benign 26-33442933-C-T734.52e-5-3.808Likely Benign0.079Likely BenignLikely Benign0.075Likely Benign-0.80Neutral0.761Possibly Damaging0.321Benign4.24Benign0.03Affected4.073-3-35.416.04
c.3404A>CK1135TLikely BenignConflicting 26-33443956-A-C16.75e-7-4.778Likely Benign0.779Likely PathogenicLikely Benign0.210Likely Benign-0.90Neutral0.411Benign0.321Benign5.46Benign0.10Tolerated4.3220-13.2-27.07
c.3405G>CK1135NLikely BenignUncertain 1-5.715Likely Benign0.960Likely PathogenicLikely Pathogenic0.166Likely Benign-0.97Neutral0.411Benign0.321Benign5.43Benign0.07Tolerated4.322100.4-14.07
c.431C>TT144MLikely PathogenicUncertain 26-33432728-C-T21.30e-6-11.228Likely Pathogenic0.922Likely PathogenicAmbiguous0.118Likely Benign-3.16Deleterious0.913Possibly Damaging0.333Benign3.73Benign0.00Affected3.615-1-12.630.09
c.1199T>AV400E
(3D Viewer)
Likely PathogenicC2Uncertain 1-13.686Likely Pathogenic0.998Likely PathogenicLikely Pathogenic0.810Likely Pathogenic3.70Destabilizing0.22.46Destabilizing3.08Destabilizing2.29Destabilizing-4.88Deleterious0.920Possibly Damaging0.335Benign5.31Benign0.00Affected3.3827-2-2-7.729.98249.1-38.8-0.10.11.00.0XXXPotentially PathogenicThe iso-propyl side chain of Val400, located in an anti-parallel β sheet strand (res. Ala399-Ile411), hydrophobically packs against hydrophobic residues within the anti-parallel β sheet of the C2 domain (e.g., Ile268, Ala404, Leu325, Leu402). In the variant simulations, the negatively charged carboxylate group of the Glu400 side chain is not suitable for occupying the hydrophobic niche. Consequently, the side chain escapes the center of the C2 domain and interacts with the backbone amide groups of Leu402 in the same β strand and/or Ile269 and Glu270 in a neighboring β strand (res. Arg259-Arg272). This residue swap disrupts the hydrophobic packing and generally has extensive negative effects on the C2 domain structure. At a minimum, the residue swap could affect the C2 domain stability and membrane association.
c.3932T>CL1311PLikely BenignLikely Benign 16-33451806-T-C16.21e-7-1.831Likely Benign0.079Likely BenignLikely Benign0.123Likely Benign-0.52Neutral0.579Possibly Damaging0.335Benign2.72Benign0.18Tolerated3.775-3-3-5.4-16.04
c.2215G>CE739QLikely BenignUncertain 1-2.846Likely Benign0.161Likely BenignLikely Benign0.071Likely Benign-1.06Neutral0.801Possibly Damaging0.339Benign2.57Benign0.00Affected4.322220.0-0.98
c.407G>AR136QBenign 16-33432704-G-A139.17e-6-11.146Likely Pathogenic0.950Likely PathogenicAmbiguous0.190Likely Benign-2.26Neutral0.957Probably Damaging0.342Benign3.52Benign0.01Affected3.615111.0-28.06
c.491G>AR164QUncertain 16-33432788-G-A21.24e-6-11.208Likely Pathogenic0.600Likely PathogenicLikely Benign0.184Likely Benign-1.86Neutral0.957Probably Damaging0.342Benign3.82Benign0.00Affected3.744111.0-28.06
c.509G>AR170QPathogenic/Likely path. 6-9.021Likely Pathogenic0.798Likely PathogenicAmbiguous0.221Likely Benign-2.31Neutral0.947Possibly Damaging0.342Benign3.91Benign0.00Affected3.744111.0-28.0610.1016/j.ajhg.2020.11.011
c.3238G>TA1080SLikely BenignUncertain 16-33443790-G-T16.26e-7-3.277Likely Benign0.108Likely BenignLikely Benign0.103Likely Benign0.01Neutral0.702Possibly Damaging0.346Benign4.16Benign0.08Tolerated3.77511-2.616.00
c.1157G>AG386E
(3D Viewer)
C2Uncertain 16-33438062-G-A-9.286Likely Pathogenic0.686Likely PathogenicLikely Benign0.447Likely Benign3.69Destabilizing2.90.79Ambiguous2.24Destabilizing0.54Ambiguous-0.83Neutral0.860Possibly Damaging0.354Benign3.93Benign0.01Affected4.323-20-3.172.06
c.2582C>TS861LLikely BenignUncertain 16-33443134-C-T21.24e-6-4.966Likely Benign0.219Likely BenignLikely Benign0.144Likely Benign-2.10Neutral0.904Possibly Damaging0.355Benign3.93Benign0.07Tolerated4.323-3-24.626.08
c.2837G>AG946ELikely BenignBenign 36-33443389-G-A138.05e-6-8.793Likely Pathogenic0.257Likely BenignLikely Benign0.341Likely Benign-0.51Neutral0.818Possibly Damaging0.355Benign4.58Benign0.00Affected4.3240-2-3.172.06
c.680G>AG227E
(3D Viewer)
Likely PathogenicPHConflicting 26-33435531-G-A31.86e-6-9.186Likely Pathogenic0.996Likely PathogenicLikely Pathogenic0.792Likely Pathogenic2.56Destabilizing0.45.36Destabilizing3.96Destabilizing0.94Ambiguous-6.49Deleterious0.906Possibly Damaging0.360Benign5.72Benign0.01Affected3.43120-2-3.172.06237.7-112.10.10.30.00.3XXUncertainThe introduced residue Glu227 is located in a β hairpin loop connecting two anti-parallel β sheet strands (res. Cys219-Thr224 and Thr228-Ala232). In the variant simulations, the carboxylate group of Glu227 frequently forms a salt bridge with the amino group of the neighboring residue Lys229. Despite this interaction, the integrity of the secondary structure element is not compromised. However, the β hairpins are potential nucleation sites during the initial stages of protein folding. Additionally, since the model ends abruptly at the N-terminus, no definite conclusions can be drawn from the simulations.
c.3520G>AE1174KLikely BenignCoiled-coilUncertain 16-33444555-G-A21.24e-6-4.345Likely Benign0.898Likely PathogenicAmbiguous0.442Likely Benign-1.59Neutral0.962Probably Damaging0.367Benign5.52Benign0.03Affected4.32201-0.4-0.94
c.103G>AV35ILikely BenignUncertain 16-33423512-G-A53.10e-6-3.764Likely Benign0.081Likely BenignLikely Benign0.017Likely Benign-0.32Neutral0.672Possibly Damaging0.369Benign4.16Benign0.00Affected4.321340.314.03
c.3049T>CF1017LLikely BenignBenign 1-2.048Likely Benign0.934Likely PathogenicAmbiguous0.157Likely Benign-2.38Neutral0.798Possibly Damaging0.373Benign2.65Benign0.72Tolerated3.775021.0-34.02
c.958G>CV320L
(3D Viewer)
C2Uncertain 16-33437863-G-C63.72e-6-6.207Likely Benign0.362AmbiguousLikely Benign0.096Likely Benign-0.26Likely Benign0.21.33Ambiguous0.54Ambiguous0.51Ambiguous-1.02Neutral0.900Possibly Damaging0.373Benign1.78Pathogenic0.92Tolerated3.382321-0.414.03245.8-10.20.30.90.10.3XPotentially BenignThe isopropyl side chain of Val310, located in a β hairpin loop linking two anti-parallel β sheet strands (res. Thr305-Asn315, res. Ala322-Asp330), hydrophobically packs with the side chains of nearby residues (e.g., Leu286, Val350, Pro318). The hydrophobic Leu320 side chain mostly forms the same interactions; hence, the residue swap does not seem to negatively affect the protein structure based on the variant simulations.
c.3041G>TG1014VLikely BenignUncertain 1-4.612Likely Benign0.181Likely BenignLikely Benign0.053Likely Benign-2.47Neutral0.818Possibly Damaging0.377Benign2.72Benign0.06Tolerated3.775-1-34.642.08
c.3902C>AP1301HLikely BenignConflicting 26-33451776-C-A53.10e-6-5.756Likely Benign0.104Likely BenignLikely Benign0.232Likely Benign-1.13Neutral0.642Possibly Damaging0.378Benign2.79Benign0.04Affected3.7750-2-1.640.02
c.3310C>TP1104SLikely BenignBenign 16-33443862-C-T16.54e-7-2.330Likely Benign0.073Likely BenignLikely Benign0.088Likely Benign-0.30Neutral0.770Possibly Damaging0.404Benign2.77Benign0.10Tolerated3.775-110.8-10.04
c.406C>TR136WLikely PathogenicUncertain 2-10.453Likely Pathogenic0.989Likely PathogenicLikely Pathogenic0.237Likely Benign-4.71Deleterious0.965Probably Damaging0.416Benign3.45Benign0.00Affected3.6152-33.630.03
c.3194C>TP1065LLikely Benign 16-33443746-C-T148.71e-6-5.085Likely Benign0.089Likely BenignLikely Benign0.068Likely Benign-2.94Deleterious0.950Possibly Damaging0.419Benign2.01Pathogenic0.00Affected4.322-3-35.416.04
c.379C>TR127WUncertain 1-4.776Likely Benign0.806Likely PathogenicAmbiguous0.118Likely Benign-2.98Deleterious0.989Probably Damaging0.420Benign3.88Benign0.00Affected2-33.630.03
c.2935T>CF979LLikely BenignUncertain 1-2.341Likely Benign0.870Likely PathogenicAmbiguous0.228Likely Benign-1.00Neutral0.625Possibly Damaging0.430Benign4.22Benign0.73Tolerated4.322201.0-34.02
c.3907G>AG1303SLikely BenignUncertain 1-2.271Likely Benign0.125Likely BenignLikely Benign0.155Likely Benign-0.19Neutral0.649Possibly Damaging0.433Benign2.84Benign0.18Tolerated10-0.430.03
c.703T>CS235P
(3D Viewer)
Likely PathogenicPHLikely Pathogenic 1-14.857Likely Pathogenic0.998Likely PathogenicLikely Pathogenic0.870Likely Pathogenic4.02Destabilizing0.16.91Destabilizing5.47Destabilizing1.23Destabilizing-4.24Deleterious0.917Possibly Damaging0.446Benign5.47Benign0.01Affected3.40141-1-0.810.04201.517.00.10.0-0.60.0XPotentially PathogenicIn the WT, the hydroxyl group of Ser235, located in a β-α loop between an anti-parallel β sheet strand (res. Gly227-Phe231) and an α helix (residues Ala236-Val250), forms hydrogen bonds with the GAP domain loop residue Glu680 and with the backbone amide groups of Ala237 and Glu238 from the α helix. In the variant simulations, the pyrrolidine ring of Pro235 cannot stabilize the α helix end or maintain tertiary bonding interactions between the PH and GAP domains via hydrogen bonding as effectively as serine.
c.707C>TA236V
(3D Viewer)
PHBenign/Likely benign 26-33435558-C-T63.72e-6-8.752Likely Pathogenic0.267Likely BenignLikely Benign0.777Likely Pathogenic0.61Ambiguous0.21.08Ambiguous0.85Ambiguous0.64Ambiguous-3.55Deleterious0.981Probably Damaging0.446Benign5.79Benign0.03Affected3.4014002.428.05213.8-44.70.00.0-0.20.2XPotentially BenignThe methyl side chain of Ala236, located on an α helix (residues Ala236-Val250) facing an anti-parallel β sheet strand (residues Ile205-Val209), interacts hydrophobically with nearby residues such as Arg239 and Phe218. In the variant simulations, the isopropyl branched hydrocarbon side chain of Val236 maintains similar hydrophobic interactions as alanine in the WT, with an overall arrangement remarkably similar to Ala236. The residue swap does not affect the protein structure based on the simulations.
c.2243T>GL748RLikely BenignConflicting 26-33441708-T-G31.86e-6-3.331Likely Benign0.245Likely BenignLikely Benign0.055Likely Benign-0.67Neutral0.912Possibly Damaging0.448Possibly Damaging2.73Benign0.02Affected4.322-3-2-8.343.03
c.3983G>CR1328PLikely BenignBenign 16-33451857-G-C-1.220Likely Benign0.466AmbiguousLikely Benign0.060Likely Benign-2.01Neutral0.927Possibly Damaging0.452Possibly Damaging4.06Benign0.01Affected3.7750-22.9-59.07
c.1058T>CL353P
(3D Viewer)
Likely PathogenicC2Uncertain 1-7.913In-Between0.936Likely PathogenicAmbiguous0.464Likely Benign4.63Destabilizing0.110.19Destabilizing7.41Destabilizing2.17Destabilizing-3.70Deleterious0.947Possibly Damaging0.454Possibly Damaging1.29Pathogenic0.02Affected3.3725-3-3-5.4-16.04
c.3119G>TG1040VLikely PathogenicUncertain 16-33443671-G-T42.48e-6-3.453Likely Benign0.645Likely PathogenicLikely Benign0.774Likely Pathogenic-2.89Deleterious0.827Possibly Damaging0.456Possibly Damaging-0.74Pathogenic0.01Affected3.775-1-34.642.08
c.1205T>GL402R
(3D Viewer)
Likely PathogenicC2Likely Pathogenic1-13.800Likely Pathogenic0.997Likely PathogenicLikely Pathogenic0.522Likely Pathogenic4.10Destabilizing0.23.82Destabilizing3.96Destabilizing2.24Destabilizing-4.69Deleterious0.967Probably Damaging0.459Possibly Damaging3.69Benign0.00Affected3.3828-3-2-8.343.03259.5-55.40.00.01.40.0XXXPotentially PathogenicThe iso-butyl side chain of Leu402, located in an anti-parallel β sheet strand (res. Ala399-Ile411), packs with residues inside the hydrophobic core of the C2 domain (e.g., Ile268, Ala404, Leu266, Val400). In the variant simulations, the positively charged guanidinium group of the Arg402 side chain is not suitable for the hydrophobic niche. Consequently, the side chain moves outward from the hydrophobic C2 domain core and stacks with the phenol ring of Tyr363 or forms H-bonds with the carboxamide group of the Gln361 side chain in the β sheet strand (res. Thr359-Tyr364). This movement induces extensive negative effects on the C2 domain structure.
c.3355G>AG1119RBenign 16-33443907-G-A644.23e-5-8.489Likely Pathogenic0.473AmbiguousLikely Benign0.303Likely Benign0.10Neutral0.969Probably Damaging0.462Possibly Damaging4.03Benign0.10Tolerated4.322-3-2-4.199.14
c.1610C>TA537V
(3D Viewer)
Likely BenignGAPLikely Benign 16-33438853-C-T74.34e-6-6.888Likely Benign0.120Likely BenignLikely Benign0.382Likely Benign0.54Ambiguous0.0-0.05Likely Benign0.25Likely Benign0.41Likely Benign-1.97Neutral0.977Probably Damaging0.469Possibly Damaging-1.26Pathogenic0.24Tolerated3.3735002.428.05220.3-45.10.00.0-0.70.1XPotentially BenignAla537 is located on the outer surface of an α-helix (res. Ala533-Val560). The methyl group of Ala537 is on the surface and does not form any interactions. In the variant simulations, the iso-propyl side chain of Val537 is also on the surface, similar to Ala537 in the WT, causing no negative structural effects.
c.3377G>AG1126DUncertain 1-8.888Likely Pathogenic0.432AmbiguousLikely Benign0.376Likely Benign-0.65Neutral0.906Possibly Damaging0.473Possibly Damaging4.82Benign0.02Affected3.7751-1-3.158.04
c.2912C>AP971HLikely BenignUncertain 16-33443464-C-A16.20e-7-5.243Likely Benign0.086Likely BenignLikely Benign0.039Likely Benign-1.11Neutral0.898Possibly Damaging0.477Possibly Damaging3.89Benign0.00Affected4.322-20-1.640.02
c.88C>TH30YLikely BenignUncertain 1-3.047Likely Benign0.115Likely BenignLikely Benign0.082Likely Benign-1.84Neutral0.273Benign0.478Possibly Damaging3.99Benign0.00Affected4.321021.926.03
c.382C>AP128TLikely BenignUncertain 16-33432247-C-A16.20e-7-4.217Likely Benign0.267Likely BenignLikely Benign0.075Likely Benign-0.96Neutral0.952Possibly Damaging0.500Possibly Damaging4.19Benign0.35Tolerated3.744-100.93.99
c.3209_3210delinsCAR1070TLikely BenignUncertain 1-5.093Likely Benign0.860Likely PathogenicAmbiguous-2.35Neutral0.948Possibly Damaging0.507Possibly Damaging3.78Benign0.01Affected3.775-1-13.8-55.08
c.2305C>TL769FLikely BenignUncertain 1-5.044Likely Benign0.146Likely BenignLikely Benign0.060Likely Benign-0.89Neutral0.925Possibly Damaging0.510Possibly Damaging3.94Benign0.02Affected20-1.034.02
c.484C>TR162CPathogenic 2-8.157Likely Pathogenic0.787Likely PathogenicAmbiguous0.150Likely Benign-2.05Neutral0.988Probably Damaging0.513Possibly Damaging4.00Benign0.11Tolerated3.744-4-37.0-53.05
c.485G>AR162HUncertain 16-33432782-G-A21.24e-6-9.730Likely Pathogenic0.480AmbiguousLikely Benign0.167Likely Benign-1.13Neutral0.957Probably Damaging0.513Possibly Damaging4.03Benign0.12Tolerated3.744201.3-19.05
c.2015C>TT672M
(3D Viewer)
GAPConflicting 26-33441274-C-T191.18e-5-9.472Likely Pathogenic0.174Likely BenignLikely Benign0.127Likely Benign0.31Likely Benign0.41.52Ambiguous0.92Ambiguous0.41Likely Benign-4.34Deleterious0.993Probably Damaging0.520Possibly Damaging3.39Benign0.00Affected3.4025-1-12.630.09231.9-52.91.10.10.50.0XXPotentially PathogenicThe hydroxyl group of Thr672, located in an entangled α-α loop connecting the two α-helices (res. Ser641-Glu666 and res. Leu685-Val699), is involved in a highly coordinated hydrogen-bonding network between residues from two α-helices (res. Ser641-Glu666 and res. Arg563-Glu578) and from the α-α loop itself, such as Lys566, Glu666, and Asn669. Met672 can only form a hydrogen bond with the amino group of the Lys566 side chain via its backbone carbonyl group. Nevertheless, the Lys566-Glu666 salt bridge forms intermittently. This is possible because Asn669 keeps the carboxylate group of Glu666 in the vicinity through hydrogen bonding, and the hydrophobic side chain of Met stays mostly rotated away from the salt bridge. Consequently, no drastic disruption of the hydrogen-bond network that keeps the loop close to the helices occurs in the variant simulations.
c.4000A>GN1334DUncertain 16-33451874-A-G-4.584Likely Benign0.674Likely PathogenicLikely Benign0.126Likely Benign-3.06Deleterious0.886Possibly Damaging0.522Possibly Damaging3.55Benign0.00Affected3.775120.00.98
c.3574C>GL1192VLikely BenignCoiled-coilUncertain 1-4.132Likely Benign0.471AmbiguousLikely Benign0.041Likely Benign-0.89Neutral0.779Possibly Damaging0.527Possibly Damaging2.69Benign0.16Tolerated210.4-14.03
c.1966G>CE656Q
(3D Viewer)
GAPUncertain 16-33441225-G-C16.20e-7-9.145Likely Pathogenic0.766Likely PathogenicLikely Benign0.249Likely Benign-0.14Likely Benign0.0-0.81Ambiguous-0.48Likely Benign0.25Likely Benign-2.29Neutral0.980Probably Damaging0.528Possibly Damaging3.46Benign0.02Affected3.3924220.0-0.98224.31.70.00.10.10.0XPotentially BenignThe carboxylate side chain of Glu656, located on an α helix (res. Ser641-Glu666), frequently forms a hydrogen bond with the nearby residue Ser659 on the same α helix. In the variant simulations, the carboxamide side chain of Gln656 alternatively forms a hydrogen bond with either Ser659 or Glu548 on an opposing helix (res. Ala533-Val560).Although the frequent interaction between Gln656 and Glu548 may strengthen or stabilize the tertiary structure assembly, the effect is likely to be marginal.
c.2567A>GN856SLikely BenignUncertain 16-33443119-A-G21.24e-6-2.104Likely Benign0.064Likely BenignLikely Benign0.040Likely Benign-1.54Neutral0.901Possibly Damaging0.535Possibly Damaging4.16Benign0.30Tolerated3.883112.7-27.03
c.3103C>AP1035TLikely BenignUncertain 1-4.447Likely Benign0.426AmbiguousLikely Benign0.087Likely Benign-0.96Neutral0.901Possibly Damaging0.537Possibly Damaging2.72Benign0.23Tolerated3.7750-10.93.99
c.458C>AT153NLikely BenignConflicting 3-0.739Likely Benign0.226Likely BenignLikely Benign0.161Likely Benign0.88Neutral0.888Possibly Damaging0.537Possibly Damaging4.23Benign0.81Tolerated3.61500-2.813.00
c.196C>GP66ALikely BenignUncertain 1-2.845Likely Benign0.891Likely PathogenicAmbiguous0.091Likely Benign-1.56Neutral0.805Possibly Damaging0.539Possibly Damaging4.04Benign0.00Affected4.3211-13.4-26.04
c.68A>GD23GLikely BenignUncertain 1-2.622Likely Benign0.684Likely PathogenicLikely Benign0.100Likely Benign-2.45Neutral0.805Possibly Damaging0.539Possibly Damaging3.50Benign0.00Affected1-13.1-58.04
c.2596G>AV866ILikely BenignConflicting 36-33443148-G-A53.10e-6-4.652Likely Benign0.118Likely BenignLikely Benign0.059Likely Benign-0.39Neutral0.957Probably Damaging0.541Possibly Damaging2.69Benign0.27Tolerated3.824430.314.03
c.2818G>CG940RLikely BenignBenign 16-33443370-G-C53.10e-6-6.169Likely Benign0.480AmbiguousLikely Benign0.060Likely Benign0.02Neutral0.922Possibly Damaging0.543Possibly Damaging2.73Benign0.15Tolerated3.775-3-2-4.199.14
c.3638A>GN1213SLikely BenignCoiled-coilBenign 16-33446630-A-G138.05e-6-4.086Likely Benign0.081Likely BenignLikely Benign0.094Likely Benign-0.56Neutral0.906Possibly Damaging0.551Possibly Damaging2.82Benign0.68Tolerated3.775112.7-27.0310.1016/j.ajhg.2020.11.011
c.1042G>AV348M
(3D Viewer)
C2Uncertain 1-7.076In-Between0.546AmbiguousLikely Benign0.191Likely Benign-1.19Ambiguous0.10.72Ambiguous-0.24Likely Benign0.76Ambiguous-1.62Neutral0.966Probably Damaging0.564Possibly Damaging1.58Pathogenic0.03Affected3.372521-2.332.06253.8-47.4-0.30.10.20.1XPotentially BenignThe iso-propyl side chain of Val348, located in an anti-parallel β sheet strand (res. Gly341-Pro349), packs against multiple hydrophobic C2 domain residues (e.g., Leu353, Leu323, Leu402). In the variant simulations, the thioether side chain of Met348 can form similar interactions as valine due to its comparable hydrophobic profile. In fact, the thioether group of methionine can even stack favorably with the phenol ring of Tyr363 in the anti-parallel β sheet strand (res. Ala399-Ile411). Overall, the residue swap does not appear to cause negative effects on the protein structure based on the simulations.
c.3056G>TR1019LLikely PathogenicUncertain 16-33443608-G-T21.24e-6-5.194Likely Benign0.752Likely PathogenicLikely Benign0.110Likely Benign-3.57Deleterious0.800Possibly Damaging0.573Possibly Damaging2.40Pathogenic0.01Affected3.775-2-38.3-43.03
c.2216A>TE739VLikely BenignUncertain 1-3.136Likely Benign0.274Likely BenignLikely Benign0.085Likely Benign-1.86Neutral0.891Possibly Damaging0.575Possibly Damaging2.47Pathogenic0.00Affected4.322-2-27.7-29.98
c.407G>CR136PLikely PathogenicUncertain 1-11.952Likely Pathogenic0.981Likely PathogenicLikely Pathogenic0.277Likely Benign-3.72Deleterious0.910Possibly Damaging0.578Possibly Damaging3.47Benign0.00Affected3.6150-22.9-59.07
c.3038C>GS1013CLikely BenignUncertain 16-33443590-C-G42.48e-6-6.745Likely Benign0.110Likely BenignLikely Benign0.058Likely Benign-2.06Neutral0.898Possibly Damaging0.579Possibly Damaging2.64Benign0.05Affected3.7750-13.316.06
c.3956C>GA1319GLikely BenignUncertain 26-33451830-C-G-3.927Likely Benign0.084Likely BenignLikely Benign0.128Likely Benign-0.74Neutral0.819Possibly Damaging0.581Possibly Damaging4.07Benign0.06Tolerated3.77510-2.2-14.03
c.2900G>TR967LLikely BenignUncertain 16-33443452-G-T16.20e-7-3.496Likely Benign0.164Likely BenignLikely Benign0.123Likely Benign-0.99Neutral0.959Probably Damaging0.586Possibly Damaging4.15Benign0.75Tolerated4.322-2-38.3-43.03
c.249A>TR83SLikely BenignUncertain 1-2.550Likely Benign0.999Likely PathogenicLikely Pathogenic0.094Likely Benign-1.87Neutral0.909Possibly Damaging0.587Possibly Damaging3.19Benign0.00Affected4.3210-13.7-69.11
c.2635_2636delinsAAA879KLikely BenignLikely Benign 1-5.877Likely Benign0.757Likely PathogenicLikely Benign-0.71Neutral0.969Probably Damaging0.593Possibly Damaging2.69Benign0.21Tolerated3.775-1-1-5.757.10
c.3192G>CQ1064HLikely BenignUncertain 1-4.576Likely Benign0.162Likely BenignLikely Benign0.063Likely Benign-0.66Neutral0.938Possibly Damaging0.596Possibly Damaging4.15Benign0.05Affected300.39.01
c.899C>TS300F
(3D Viewer)
Likely PathogenicC2Uncertain 1-10.222Likely Pathogenic0.353AmbiguousLikely Benign0.117Likely Benign-0.29Likely Benign0.40.16Likely Benign-0.07Likely Benign0.04Likely Benign-2.66Deleterious0.975Probably Damaging0.596Possibly Damaging1.52Pathogenic0.01Affected3.4719-3-23.660.10233.6-67.6-0.10.00.40.2XXPotentially PathogenicThe hydroxyl group of the Ser300 side chain, located in a β hairpin loop linking two anti-parallel β sheet strands (res. Met289-Pro298, res. Thr305-Asn315), hydrogen bonds with the guanidinium group of Arg299 and the backbone amide group and side chain of Ser302. Thus, in the WT simulations, it contributes to the β hairpin stability. In the variant simulations, the phenol ring of Phe300 cannot form any side chain-related hydrogen bonds, and Arg299 is moved away from its central hairpin loop position.β hairpins are potential nucleation sites during the initial stages of protein folding, so even minor changes in them could be significant. Due to its location near the membrane surface, the residue swap could also affect the C2 loop dynamics and SynGAP-membrane association. However, this is beyond the scope of the solvent-only simulations to unravel.
c.1964T>AL655Q
(3D Viewer)
Likely BenignGAPUncertain 1-5.278Likely Benign0.144Likely BenignLikely Benign0.139Likely Benign-0.01Likely Benign0.00.69Ambiguous0.34Likely Benign-0.15Likely Benign0.61Neutral0.955Possibly Damaging0.602Possibly Damaging3.59Benign0.65Tolerated3.3924-2-2-7.314.97229.9-8.60.00.00.40.0XPotentially BenignThe iso-butyl side chain of Leu655, located on the surface of an α helix (res. Ser641-Glu666), is not involved in any interactions in the WT simulations. In the variant simulations, the carboxamide side chain of Gln655 dynamically interacts with neighboring residues (e.g., Glu651, Glu656, Arg544) on the protein surface, with no negative structural effects.
c.1998G>CE666D
(3D Viewer)
Likely PathogenicGAPUncertain 1-8.820Likely Pathogenic0.704Likely PathogenicLikely Benign0.197Likely Benign0.88Ambiguous0.00.37Likely Benign0.63Ambiguous1.05Destabilizing-2.69Deleterious0.992Probably Damaging0.603Possibly Damaging3.43Benign0.06Tolerated3.3828320.0-14.03237.216.50.00.0-0.30.1XPotentially PathogenicThe carboxylate group of Glu666, located on the α-helix (res. Ser641-Glu666), is involved in a highly coordinated hydrogen-bonding network between residues from two α-helices (res. Ser641-Glu666 and res. Arg563-Glu578) and from the α-α loop connecting the two α-helices (res. Ser641-Glu666 and res. Leu685-Val699), such as Lys566, Thr672, and Asn669, in the WT simulations. In the variant simulations, the shorter side chain of Asp666 cannot maintain these interactions as efficiently as Glu666 in the WT, resulting in a less coordinated hydrogen-bond network.
c.3323G>TS1108IUncertain 16-33443875-G-T-3.666Likely Benign0.292Likely BenignLikely Benign0.145Likely Benign-3.73Deleterious0.971Probably Damaging0.604Possibly Damaging2.44Pathogenic0.10Tolerated3.775-2-15.326.08
c.140G>AR47QLikely BenignLikely Benign 16-33423549-G-A42.48e-6-4.989Likely Benign0.347AmbiguousLikely Benign0.096Likely Benign-0.57Neutral0.829Possibly Damaging0.614Possibly Damaging4.12Benign0.00Affected4.321111.0-28.0610.1016/j.ajhg.2020.11.011
c.74G>AR25QLikely BenignUncertain 16-33423483-G-A159.29e-6-4.126Likely Benign0.212Likely BenignLikely Benign0.038Likely Benign-0.70Neutral0.829Possibly Damaging0.614Possibly Damaging4.01Benign0.00Affected4.321111.0-28.06
c.92G>AR31QLikely BenignUncertain 16-33423501-G-A74.34e-6-4.434Likely Benign0.136Likely BenignLikely Benign0.051Likely Benign-0.92Neutral0.829Possibly Damaging0.614Possibly Damaging4.01Benign0.00Affected4.321111.0-28.06
c.2704G>AA902TLikely BenignLikely Benign 16-33443256-G-A362.23e-5-4.966Likely Benign0.116Likely BenignLikely Benign0.075Likely Benign-1.11Neutral0.951Possibly Damaging0.617Possibly Damaging2.61Benign0.01Affected3.77510-2.530.03
c.2557G>CG853RLikely BenignUncertain 1-4.749Likely Benign0.366AmbiguousLikely Benign0.091Likely Benign-1.27Neutral0.846Possibly Damaging0.624Possibly Damaging4.18Benign0.00Affected-3-2-4.199.14
c.2900G>AR967QLikely BenignBenign/Likely benign 26-33443452-G-A311.92e-5-3.057Likely Benign0.080Likely BenignLikely Benign0.104Likely Benign-0.01Neutral0.994Probably Damaging0.626Possibly Damaging4.21Benign0.36Tolerated4.322111.0-28.06
c.3026A>CE1009ALikely PathogenicUncertain 1-3.118Likely Benign0.679Likely PathogenicLikely Benign0.109Likely Benign-3.06Deleterious0.980Probably Damaging0.630Possibly Damaging2.39Pathogenic0.01Affected3.7750-15.3-58.04
c.2393C>TP798LLikely BenignSH3-binding motifUncertain 26-33442945-C-T63.72e-6-5.640Likely Benign0.074Likely BenignLikely Benign0.042Likely Benign-0.86Neutral0.981Probably Damaging0.631Possibly Damaging4.21Benign0.00Affected4.321-3-35.416.04
c.2690C>TS897LLikely BenignUncertain 1-4.034Likely Benign0.299Likely BenignLikely Benign0.028Likely Benign-1.71Neutral0.901Possibly Damaging0.636Possibly Damaging2.66Benign0.01Affected-3-24.626.08
c.291G>TE97DLikely BenignUncertain 36-33425899-G-T-3.239Likely Benign0.077Likely BenignLikely Benign0.081Likely Benign-0.49Neutral0.880Possibly Damaging0.636Possibly Damaging4.12Benign0.00Affected4.321320.0-14.03
c.3529G>AE1177KLikely BenignCoiled-coilUncertain 1-3.413Likely Benign0.944Likely PathogenicAmbiguous0.560Likely Pathogenic-1.75Neutral0.905Possibly Damaging0.637Possibly Damaging5.44Benign0.11Tolerated4.32201-0.4-0.94
c.196C>TP66SLikely BenignBenign 16-33425804-C-T21.24e-6-2.760Likely Benign0.929Likely PathogenicAmbiguous0.081Likely Benign-1.69Neutral0.909Possibly Damaging0.641Possibly Damaging4.01Benign0.00Affected4.3211-10.8-10.04
c.2255C>TS752LLikely BenignUncertain 26-33441720-C-T63.72e-6-3.386Likely Benign0.182Likely BenignLikely Benign0.195Likely Benign-2.09Neutral0.993Probably Damaging0.641Possibly Damaging1.51Pathogenic0.01Affected3.995-3-24.626.08
c.3502A>GI1168VLikely BenignUncertain 1-3.263Likely Benign0.524AmbiguousLikely Benign0.363Likely Benign-0.14Neutral0.876Possibly Damaging0.643Possibly Damaging5.47Benign0.84Tolerated3.88343-0.3-14.03
c.913A>GT305A
(3D Viewer)
Likely BenignC2Conflicting 26-33437818-A-G138.05e-6-4.307Likely Benign0.078Likely BenignLikely Benign0.144Likely Benign1.30Ambiguous0.61.55Ambiguous1.43Ambiguous0.77Ambiguous-2.10Neutral0.939Possibly Damaging0.645Possibly Damaging1.76Pathogenic0.12Tolerated3.4020102.5-30.03177.943.5-0.20.10.40.0UncertainThe hydroxyl group of Thr305, located at the beginning of an anti-parallel β strand (res. Thr305-Asn315), hydrogen bonds with the carboxylate groups of Glu270 and Asp304 in the anti-parallel β strand and the adjacent β hairpin loop, respectively. In the variant simulations, the methyl group of the Ala305 side chain cannot hydrogen bond with either of the acidic residues, which could weaken the integrity of the tertiary structure and the β hairpin loop. Indeed, the guanidinium group of Arg299 does not acquire its central hairpin loop position due to the residue swap.β hairpins are potential nucleation sites during the initial stages of protein folding, so even minor changes in them could be significant. Due to its location near the membrane surface, the residue swap could also affect the C2 loop dynamics and SynGAP-membrane association. However, this is beyond the scope of the solvent-only simulations to unravel.
c.1408A>CM470L
(3D Viewer)
Likely PathogenicGAPLikely Benign 16-33438440-A-C16.20e-7-8.993Likely Pathogenic0.406AmbiguousLikely Benign0.678Likely Pathogenic0.73Ambiguous0.10.84Ambiguous0.79Ambiguous1.04Destabilizing-2.72Deleterious0.484Possibly Damaging0.654Possibly Damaging-1.22Pathogenic0.16Tolerated3.3734421.9-18.03225.317.90.00.0-0.80.5XPotentially BenignThe thioether group of Met470, located in the middle of an α helix (res. Ala461–Phe476), interacts with hydrophobic residues in the inter-helix space (e.g., Val473, Leu558) formed by two other α helices (res. Ser604–Arg581, res. Pro562–Arg579). In the WT simulations, Met470 also packs against the positively charged guanidinium groups of Arg575, Arg429, and Arg579, which form salt bridges with the negatively charged carboxylate groups of the Asp474 and Asp467 side chains at the protein surface. In the variant simulations, the iso-butyl side chain of Leu470 packs similarly with the hydrophobic residues as methionine, resulting in no negative effects on the protein structure during the simulation.
c.391G>CG131RUncertain 1-6.564Likely Benign0.983Likely PathogenicLikely Pathogenic0.099Likely Benign-3.82Deleterious0.983Probably Damaging0.656Possibly Damaging3.92Benign0.00Affected3.615-2-3-4.199.14
c.3906G>CL1302FUncertain 1-5.674Likely Benign0.148Likely BenignLikely Benign0.211Likely Benign-2.70Deleterious0.960Probably Damaging0.657Possibly Damaging1.53Pathogenic0.00Affected20-1.034.02
c.3181G>TG1061CLikely BenignConflicting 26-33443733-G-T63.73e-6-9.511Likely Pathogenic0.119Likely BenignLikely Benign0.409Likely Benign-1.46Neutral0.938Possibly Damaging0.665Possibly Damaging3.97Benign0.00Affected4.322-3-32.946.09
c.3788T>CI1263TLikely PathogenicCoiled-coilUncertain 16-33446780-T-C21.24e-6-6.564Likely Benign0.962Likely PathogenicLikely Pathogenic0.529Likely Pathogenic-4.15Deleterious0.946Possibly Damaging0.673Possibly Damaging1.81Pathogenic0.00Affected3.7750-1-5.2-12.05
c.2525C>AS842YLikely PathogenicLikely Pathogenic 1-16.124Likely Pathogenic0.995Likely PathogenicLikely Pathogenic0.191Likely Benign-4.28Deleterious0.944Possibly Damaging0.676Possibly Damaging1.97Pathogenic0.00Affected3.775-3-2-0.576.10
c.182A>CE61ALikely BenignUncertain 1-5.235Likely Benign0.453AmbiguousLikely Benign0.074Likely Benign-1.52Neutral0.458Possibly Damaging0.678Possibly Damaging4.12Benign0.00Affected0-15.3-58.04
c.187G>AE63KLikely BenignUncertain 1-4.976Likely Benign0.894Likely PathogenicAmbiguous0.103Likely Benign-0.70Neutral0.458Possibly Damaging0.678Possibly Damaging3.98Benign0.00Affected4.32110-0.4-0.94
c.2224C>TR742WLikely BenignUncertain 16-33441689-C-T63.72e-6-7.725In-Between0.133Likely BenignLikely Benign0.079Likely Benign-1.71Neutral0.992Probably Damaging0.684Possibly Damaging2.66Benign0.01Affected4.322-323.630.03
c.3002T>CL1001PLikely BenignUncertain 1-3.071Likely Benign0.209Likely BenignLikely Benign0.113Likely Benign-1.02Neutral0.966Probably Damaging0.690Possibly Damaging2.65Benign0.00Affected4.324-3-3-5.4-16.04
c.1153T>CS385P
(3D Viewer)
Likely BenignC2Uncertain 16-33438058-T-C-5.431Likely Benign0.123Likely BenignLikely Benign0.385Likely Benign0.91Ambiguous0.6-0.90Ambiguous0.01Likely Benign0.19Likely Benign-0.26Neutral0.676Possibly Damaging0.693Possibly Damaging4.63Benign0.04Affected4.3231-1-0.810.04210.318.51.80.90.30.0UncertainSer385 is located in the Gly-rich Ω loop (res. Pro364-Pro398) between two anti-parallel β sheet strands (res. Thr359-Pro364, res. Ala399-Ile411). Because the Ω loop is assumed to directly interact with the membrane, it moves arbitrarily throughout the WT solvent simulations. The Ω loop potentially plays a crucial role in the SynGAP-membrane complex association, stability, and dynamics. However, this aspect cannot be fully addressed through solvent simulations alone.Ω loops are known to play major roles in protein functions that require flexibility, and so they are rich in glycine residues, prolines, and, to a lesser extent, small hydrophilic residues to ensure maximum flexibility. Thus, the variant’s Pro385 is potentially tolerated in the Ω loop. However, since the effects on Gly-rich Ω loop dynamics can only be well studied through the SynGAP-membrane complex, no definite conclusions can be drawn.
c.3313C>TR1105WUncertain 16-33443865-C-T63.93e-6-6.911Likely Benign0.488AmbiguousLikely Benign0.133Likely Benign-4.34Deleterious0.999Probably Damaging0.696Possibly Damaging2.42Pathogenic0.02Affected3.775-323.630.03
c.3410A>CH1137PLikely BenignBenign 16-33444445-A-C127.44e-6-2.098Likely Benign0.054Likely BenignLikely Benign0.419Likely Benign-1.93Neutral0.925Possibly Damaging0.703Possibly Damaging5.29Benign0.00Affected4.324-201.6-40.02
c.1147G>TG383W
(3D Viewer)
C2Uncertain 16-33438052-G-T16.22e-7-10.161Likely Pathogenic0.439AmbiguousLikely Benign0.469Likely Benign5.81Destabilizing3.64.44Destabilizing5.13Destabilizing0.08Likely Benign-1.01Neutral0.959Probably Damaging0.704Possibly Damaging4.09Benign0.00Affected4.327-2-7-0.5129.16
c.1154C>TS385L
(3D Viewer)
Likely BenignC2Uncertain 26-33438059-C-T94.60e-5-6.018Likely Benign0.167Likely BenignLikely Benign0.304Likely Benign0.16Likely Benign0.10.08Likely Benign0.12Likely Benign-0.26Likely Benign-0.68Neutral0.829Possibly Damaging0.706Possibly Damaging4.63Benign0.01Affected4.323-3-24.626.08244.6-50.10.00.6-0.10.1UncertainSer385 is located in the Gly-rich Ω loop (res. Pro364-Pro398) between two anti-parallel β sheet strands (res. Thr359-Pro364, res. Ala399-Ile411). Because the Ω loop is assumed to directly interact with the membrane, it moves arbitrarily throughout the WT solvent simulations. The Ω loop potentially plays a crucial role in the SynGAP-membrane complex association, stability, and dynamics. However, this aspect cannot be fully addressed through solvent simulations alone.Ω loops are known to play major roles in protein functions that require flexibility, and thus hydrophobic residues like leucine are rarely tolerated. Although no negative structural effects are observed in the variant simulations, Leu385 may exert drastic effects on the SynGAP-membrane complex dynamics and stability. However, since the effects on Gly-rich Ω loop dynamics can only be studied through the SynGAP-membrane complex, no definite conclusions can be drawn.
c.155C>TS52LUncertain 16-33423564-C-T16.20e-7-7.199In-Between0.688Likely PathogenicLikely Benign0.087Likely Benign-1.41Neutral0.829Possibly Damaging0.706Possibly Damaging4.10Benign0.00Affected4.321-3-24.626.08
c.59C>TP20LLikely BenignUncertain 3-3.289Likely Benign0.464AmbiguousLikely Benign0.100Likely Benign-0.44Neutral0.909Possibly Damaging0.713Possibly Damaging4.27Benign0.00Affected4.321-3-35.416.04
c.2752G>AA918TLikely BenignUncertain 16-33443304-G-A16.20e-7-4.139Likely Benign0.083Likely BenignLikely Benign0.065Likely Benign-1.09Neutral0.980Probably Damaging0.721Possibly Damaging2.64Benign0.03Affected4.32401-2.530.03
c.2864C>TS955FConflicting 46-33443416-C-T955.89e-5-7.374In-Between0.176Likely BenignLikely Benign0.093Likely Benign-1.73Neutral0.977Probably Damaging0.721Possibly Damaging2.32Pathogenic0.00Affected3.775-3-23.660.10
c.3638A>CN1213TLikely BenignCoiled-coilConflicting 26-33446630-A-C462.85e-5-5.428Likely Benign0.266Likely BenignLikely Benign0.097Likely Benign-1.08Neutral0.959Probably Damaging0.721Possibly Damaging2.74Benign1.00Tolerated3.775002.8-13.00
c.250C>GR84GUncertain 1-6.627Likely Benign0.989Likely PathogenicLikely Pathogenic0.139Likely Benign-2.64Deleterious0.962Probably Damaging0.726Possibly Damaging3.68Benign0.00Affected4.321-3-24.1-99.14
c.272A>GE91GLikely BenignLikely Benign 1-3.226Likely Benign0.783Likely PathogenicLikely Benign0.110Likely Benign-2.18Neutral0.947Possibly Damaging0.727Possibly Damaging3.86Benign0.00Affected4.3210-23.1-72.06
c.3142G>CG1048RLikely BenignUncertain 1-4.305Likely Benign0.435AmbiguousLikely Benign0.503Likely Pathogenic-0.54Neutral0.919Possibly Damaging0.728Possibly Damaging2.54Benign0.10Tolerated3.775-2-3-4.199.14
c.3179G>TG1060VLikely BenignBenign 16-33443731-G-T16.22e-7-6.966Likely Benign0.103Likely BenignLikely Benign0.369Likely Benign-0.73Neutral0.986Probably Damaging0.728Possibly Damaging2.63Benign0.33Tolerated4.322-1-34.642.08
c.3308G>AR1103HLikely BenignBenign/Likely benign 36-33443860-G-A312.03e-5-3.622Likely Benign0.156Likely BenignLikely Benign0.116Likely Benign-1.97Neutral0.996Probably Damaging0.733Possibly Damaging2.49Pathogenic0.01Affected3.775201.3-19.05
c.2765G>AR922QLikely BenignBenign 16-33443317-G-A74.34e-6-3.295Likely Benign0.189Likely BenignLikely Benign0.085Likely Benign-0.27Neutral0.992Probably Damaging0.736Possibly Damaging2.57Benign0.20Tolerated3.775111.0-28.06
c.2050G>AD684N
(3D Viewer)
Likely PathogenicGAPUncertain 1-13.155Likely Pathogenic0.985Likely PathogenicLikely Pathogenic0.382Likely Benign1.47Ambiguous0.81.76Ambiguous1.62Ambiguous0.37Likely Benign-4.99Deleterious0.999Probably Damaging0.746Possibly Damaging3.39Benign0.01Affected210.0-0.98
c.3151G>TG1051CLikely Pathogenic 1-9.050Likely Pathogenic0.122Likely BenignLikely Benign0.497Likely Benign-0.90Neutral0.971Probably Damaging0.750Possibly Damaging-0.74Pathogenic0.10Tolerated3.775-3-32.946.09
c.611C>GS204C
(3D Viewer)
Likely BenignPHUncertain 1-6.613Likely Benign0.127Likely BenignLikely Benign0.148Likely Benign0.65Ambiguous0.4-1.13Ambiguous-0.24Likely Benign0.10Likely Benign-0.64Neutral0.978Probably Damaging0.753Possibly Damaging4.13Benign0.05Affected3.44100-13.316.06223.6-13.80.60.30.00.2XUncertainThe hydroxyl-containing Ser204, located in the N-terminal loop before the first anti-parallel β sheet strand (res. Ile205-Pro208), is replaced by the thiol-containing cysteine. In the WT simulations, Ser204 simultaneously forms hydrogen bonds with the backbone carbonyl of Asp201 and the hydroxyl group of Thr224, helping to stabilize the two anti-parallel β strands (res. Ile205-Lys207 and Cys219-Thr223) at the end of the β sheet. Since the thiol group of cysteine forms weaker hydrogen bonds than the hydroxyl group of serine, Cys204 does not maintain the hydrogen bond network as stably as Ser204 in the variant simulations. However, because the model ends abruptly at the N-terminus, no definite conclusions can be drawn from the simulations.
c.3424T>CS1142PLikely BenignLikely Benign 16-33444459-T-C16.20e-7-2.713Likely Benign0.222Likely BenignLikely Benign0.107Likely Benign-2.19Neutral0.918Possibly Damaging0.761Possibly Damaging2.64Benign0.00Affected4.324-11-0.810.04
c.3920C>AP1307QLikely BenignUncertain 16-33451794-C-A-4.227Likely Benign0.114Likely BenignLikely Benign0.192Likely Benign-0.88Neutral0.988Probably Damaging0.765Possibly Damaging2.82Benign0.03Affected3.7750-1-1.931.01
c.2414T>CL805PSH3-binding motifUncertain 1-4.661Likely Benign0.444AmbiguousLikely Benign0.272Likely Benign-3.40Deleterious0.975Probably Damaging0.767Possibly Damaging2.36Pathogenic0.00Affected3.775-3-3-5.4-16.04
c.2971G>AG991RLikely BenignConflicting 36-33443523-G-A84.96e-6-3.934Likely Benign0.411AmbiguousLikely Benign0.102Likely Benign-1.20Neutral0.984Probably Damaging0.772Possibly Damaging4.11Benign0.01Affected4.322-3-2-4.199.14
c.3386T>CL1129PLikely BenignUncertain 2-2.991Likely Benign0.154Likely BenignLikely Benign0.432Likely Benign0.27Neutral0.971Probably Damaging0.773Possibly Damaging5.44Benign0.00Affected4.324-3-3-5.4-16.04
c.187G>CE63QLikely BenignUncertain 1-4.038Likely Benign0.687Likely PathogenicLikely Benign0.078Likely Benign-0.85Neutral0.659Possibly Damaging0.775Possibly Damaging3.90Benign0.00Affected4.321220.0-0.98
c.986G>AR329H
(3D Viewer)
Likely PathogenicC2Uncertain 16-33437891-G-A21.24e-6-10.154Likely Pathogenic0.769Likely PathogenicLikely Benign0.155Likely Benign2.53Destabilizing0.70.71Ambiguous1.62Ambiguous0.82Ambiguous-3.17Deleterious0.995Probably Damaging0.778Possibly Damaging4.04Benign0.05Affected3.4115201.3-19.05220.481.40.10.10.20.3UncertainThe guanidinium group of Arg329, located at the end of an anti-parallel β sheet strand (res. Ala322-Asp330), faces the negatively charged lipid bilayer surface. While the residue swap does not cause any apparent negative effects on the protein structure in the variant simulations, it could adversely affect the SynGAP-membrane association in reality. The positively charged Arg329 side chain forms hydrogen bonds with other loop residues (e.g., Ser371, Asp338) that are expected to dynamically interact with the membrane head group region. However, this phenomenon is beyond the scope of the solvent-only simulations to unravel. Notably, histidine can also be double protonated and positively charged, but this alternative protonation state was not considered in the variant simulations.
c.2753C>TA918VLikely BenignUncertain 36-33443305-C-T21.24e-6-3.684Likely Benign0.112Likely BenignLikely Benign0.119Likely Benign-1.61Neutral0.980Probably Damaging0.782Possibly Damaging2.61Benign0.03Affected4.324002.428.05
c.1792C>GL598V
(3D Viewer)
Likely PathogenicGAPUncertain 1-10.002Likely Pathogenic0.578Likely PathogenicLikely Benign0.221Likely Benign1.89Ambiguous0.11.58Ambiguous1.74Ambiguous1.01Destabilizing-2.92Deleterious0.944Possibly Damaging0.786Possibly Damaging3.21Benign0.02Affected3.3735210.4-14.03218.429.60.00.00.80.0XPotentially BenignThe iso-butyl side chain of Leu598, located on an α helix (res. Glu582-Met603), packs hydrophobically with other hydrophobic residues in the inter-helix space (e.g., Ile602, Phe594, Ile510).In the variant simulations, Val598, which has similar size and physicochemical properties to leucine, resides in the inter-helix hydrophobic space in a similar manner to Leu598 in the WT. This causes no negative effects on the protein structure.
c.3307C>TR1103CUncertain 16-33443859-C-T63.92e-6-2.440Likely Benign0.246Likely BenignLikely Benign0.140Likely Benign-3.01Deleterious0.996Probably Damaging0.787Possibly Damaging2.41Pathogenic0.01Affected3.775-3-47.0-53.05
c.2068T>CS690P
(3D Viewer)
Likely PathogenicGAPUncertain 1-14.568Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.431Likely Benign4.84Destabilizing0.34.40Destabilizing4.62Destabilizing1.42Destabilizing-4.77Deleterious0.998Probably Damaging0.790Possibly Damaging3.44Benign0.01Affected3.42171-1-0.810.04207.515.10.10.0-0.10.2XXPotentially PathogenicThe hydroxyl side chain of Ser690, located in an α-helix (res. Leu696-Leu685), forms a hydrogen bond with the backbone carbonyl group of Ser410 in an anti-parallel β-sheet of the C2 domain (res. Ile411-Ala399). In the variant simulations, the pyrrolidine side chain of Pro690 cannot form hydrogen bonds with the C2 domain residue, resulting in the loss of this inter-domain connection. Additionally, prolines lack a free amide group necessary for hydrogen bonding with the carbonyl group of Gly686, introducing a slight bend in the α-helix and compromising its integrity.
c.2768T>AI923NLikely BenignUncertain 1-0.733Likely Benign0.712Likely PathogenicLikely Benign0.108Likely Benign-1.16Neutral0.991Probably Damaging0.793Possibly Damaging2.70Benign0.13Tolerated3.775-2-3-8.00.94
c.3260C>TS1087FUncertain 1-3.843Likely Benign0.497AmbiguousLikely Benign0.105Likely Benign-2.75Deleterious0.990Probably Damaging0.796Possibly Damaging2.56Benign0.03Affected3.775-2-33.660.10
c.3154G>AG1052RUncertain 1-9.050Likely Pathogenic0.383AmbiguousLikely Benign0.497Likely Benign-0.41Neutral0.990Probably Damaging0.798Possibly Damaging3.90Benign0.10Tolerated3.775-2-3-4.199.14
c.514C>TR172WLikely PathogenicUncertain 26-33435156-C-T95.58e-6-10.258Likely Pathogenic0.878Likely PathogenicAmbiguous0.228Likely Benign-3.61Deleterious0.997Probably Damaging0.803Possibly Damaging3.95Benign0.00Affected3.6152-33.630.03
c.700C>TR234W
(3D Viewer)
Likely PathogenicPHUncertain 16-33435551-C-T31.86e-6-12.625Likely Pathogenic0.947Likely PathogenicAmbiguous0.805Likely Pathogenic0.96Ambiguous0.30.69Ambiguous0.83Ambiguous0.13Likely Benign-5.52Deleterious0.997Probably Damaging0.803Possibly Damaging5.76Benign0.01Affected3.40142-33.630.03262.839.6-0.10.0-0.20.2XPotentially PathogenicThe guanidinium group of Arg234, located in a β-α loop between an anti-parallel β sheet strand (residues Gly227-Phe231) and an α helix (res. Ala236-Val250), forms a salt bridge with the carboxylate group of Glu238 in the α helix. Occasionally, it also bonds with the GAP domain residues Ser678 and Glu680. Thus, the positively charged Arg234 could contribute to the tertiary structure assembly between the PH and GAP domains. In contrast, the indole side chain of Trp234 in the variant is located on the protein surface in the variant simulations and is unable to form any interactions.
c.59C>GP20RLikely BenignUncertain 1-3.548Likely Benign0.434AmbiguousLikely Benign0.146Likely Benign-0.15Neutral0.972Probably Damaging0.804Possibly Damaging4.33Benign0.00Affected4.3210-2-2.959.07
c.2095G>AV699M
(3D Viewer)
GAPUncertain 26-33441354-G-A84.96e-6-8.869Likely Pathogenic0.484AmbiguousLikely Benign0.276Likely Benign-0.58Ambiguous0.10.29Likely Benign-0.15Likely Benign0.96Ambiguous-2.18Neutral0.994Probably Damaging0.806Possibly Damaging3.37Benign0.03Affected3.471021-2.332.06257.8-47.20.00.00.90.1XPotentially BenignThe isopropyl side chain of Val699, located on an α-helix (res. Leu685-Gln702), packs against hydrophobic residues (e.g., Leu703, Leu696, Leu435, Leu439) in the inter-helix space. In the variant simulations, the thioether side chain of Met699 has similar physicochemical properties to Val699 in the WT, and thus, it is able to maintain similar interactions. Consequently, the mutation causes no apparent changes in the structure.
c.2302G>TD768YLikely PathogenicUncertain 16-33442460-G-T-9.866Likely Pathogenic0.824Likely PathogenicAmbiguous0.234Likely Benign-2.86Deleterious0.989Probably Damaging0.806Possibly Damaging4.01Benign0.07Tolerated3.646-4-32.248.09

Found 757 rows. Show 200 rows per page. Page 2/4 |